• Learn > Schedule of Events

Schedule of Events

The 2024 Multidisciplinary Head and Neck Cancers Symposium will take place on February 29-March 2, 2024, in Scottsdale, Arizona. The schedule of events for the meeting can be found below.

Individual presenter disclosures are linked to their name in the Schedule of Events below. You may also view all presenter disclosures at once.

All symposium abstracts are embargoed until Thursday, February 29, at 8:00 a.m. Mountain time. Once the embargo lifts, all abstracts are available on the conference planner, and digital poster viewing will be available in the virtual poster library.

Wednesday, February 28, 2024
4:00 p.m. - 6:00 p.m. Registration Open
Thursday, February 29, 2024
7:00 a.m. - 4:30 p.m. Registration Open
7:00 a.m. - 8:00 a.m. Continental Breakfast in the Exhibit Hall
7:50 a.m. - 8:00 a.m. Day One Welcome
Faye Johnson, MD, PhD, MD Anderson Cancer Center, Houston [M]
8:00 a.m. - 8:20 a.m. Patient Perspective
8:20 a.m. - 9:50 a.m. Novel Local Therapy for Recurrent Disease
Moderator: Maie St. John, MD, PhD, University of California, Los Angeles [S]

Speakers:
  • Robert Haddad, MD, Dana-Farber Cancer Institute, Boston [M]
  • Sana Karam, MD, PhD, University of Colorado Anschutz Medical Campus, Aurora, Colorado [R]
  • Young Kim, MD, PhD, Vanderbilt University Medical Center, Nashville, Tennessee [S]
  • Luc Morris, MD, FACS, Memorial Sloan Kettering Cancer Center, New York [S]
9:50 a.m. - 10:35 a.m. Keynote I: Overcoming Structural Barriers to Diverse Representation and Clinical Trials
Moderator: Kelly Malloy, MD, University of Michigan, Ann Arbor, Michigan [S]

Speaker: Carmen Guerra, MD, MSCE, FACP, University of Pennsylvania, Philadelphia [Physician]
10:35 a.m. - 11:00 a.m. Coffee Break
11:00 a.m. - 12:30 p.m. Emerging Clinical Decision Support Tools
Moderator: Alexander Pearson, MD, University of Chicago, Chicago [M]
  • AI Tools
    • ​Ben Kann, MD, Brigham and Women's Hospital, Boston [R]
  • ctDNA
    • ​Glenn Hanna, MD, Dana-Farber Cancer Institute, Boston [M]
  • TMI
    • ​Chamindie Punyadeera, PhD, Griffith University, Queensland, Australia [Professor]
  • Q&A
12:30 p.m. - 1:30 p.m. Lunch in the Exhibit Hall

Early-career and Trainee Networking Luncheon: Choosing Your Career Path
  • Musaddiq Awan, MD, Medical College of Wisconsin, Milwaukee, Wisconsin [R]
  • Ari Rosenberg, MD, University of Chicago, Chicago [M]
  • Maie St. John, MD, PhD, University of California, Los Angeles [S]
1:30 p.m. - 3:00 p.m. K. Kian Ang, MD, PhD, FASTRO, Commemorative Plenary Session
Moderator: Faye Johnson, MD, PhD, MD Anderson Cancer Center, Houston [M]
3:00 p.m. - 3:30 p.m. Coffee Break
3:30 p.m. - 4:45 p.m. Innovative Trials
Moderator: Musaddiq Awan, MD, Medical College of Wisconsin, Mayfield Heights, Ohio [R]
  • Targeting of HPV-Specific Epitopes in Viral Oropharyngeal Cancer: The Hoopika Study
  • Novel Immunotherapeutic Approaches Prior to Surgical Resection of Non-Viral Head and Neck Cancers
  • Utilizing a Neoadjuvant Radiotherapy Approach to Develop Novel Immunotherapeutic Targets in Head and Neck Cancers: The HyPR-HN Trial
  • Q&A
4:45 p.m. - 5:45 p.m. Networking Reception and Research Features in the Exhibit Hall
Friday, March 1, 2024
7:00 a.m. - 5:30 p.m. Registration Open
7:00 a.m. - 8:00 a.m. Continental Breakfast in the Exhibit Hall
7:55 a.m. - 8:00 a.m. Day Two Welcome
Cherie-Ann Nathan, MD, Louisiana State University-Health, Shreveport, Louisiana [S]
8:00 a.m. - 8:20 a.m. Patient Perspective
Speaker: Dmitry Karpeyev, PhD [Patient Speaker]
8:20 a.m. - 9:40 a.m. Advanced, Resectable cSCC in the Era of Immunotherapy: Cut Now, Later or Not at All?
Moderator: Jessica Geiger, MD, Cleveland Clinic Cancer Center, Cleveland [M]
  • PT Selection Appropriate for Immunotherapy and Avoiding Surgery
    • Shlomo Koyfman, MD, Cleveland Clinic, Cleveland [R]
  • Advocating for Neo-Adjuvant Immunotherapy Followed by Resection
    • Emily Ruiz, MD, MPH, FAAD, Brigham and Women's Hospital, Boston [S]
  • Argument for Resection Neo-Adjuvant Immunotherapy
    • Steven Chinn, MD, MPH, University of Michigan, Ann Arbor, Michigan [S]
9:40 a.m. - 10:25 a.m. Keynote II: Evolving Role of Neoadjuvant Immunotherapy in Curative-Intent Head and Neck Cancer
Moderator: Ari Rosenberg, MD, University of Chicago, Chicago [M]

Speaker: Ravindra Uppaluri, MD, PhD, Dana-Farber Cancer Center, Boston [S]
10:25 a.m. - 10:50 a.m. Coffee Break
10:50 a.m. - 12:20 p.m. Plenary II
12:20 p.m. - 1:20 p.m. Lunch in the Exhibit Hall

Early Career and Trainee Networking Luncheon: Launching Your Successful Career
  • Jessica Geiger, MD, Cleveland Clinic Cancer Center, Cleveland [M]
  • Zain Husain, MD, Southern California Permanente Medical Group, Toronto, Ontario, Canada [R]
  • Michael Moore, MD, Indiana University, Indianapolis [S]
1:20 p.m. - 2:35 p.m. Thyroid Cancer Roundtable 2024 – From Microcarcinoma to Advanced Management
Moderator: Cherie-Ann Nathan, MD, Louisiana State University-Health, Shreveport, Louisiana [S]
  • Management of Microcarcinoma Including RFA
    • ​Caitlin McMullen, MD, Moffitt Cancer Center, Tampa [S]
  • BRAF Directed Therapy for Anaplastic Carcinoma
    • ​Mark Zafereo, MD, FACS, MD Anderson Cancer Center, Houston [S]
  • Recurrent Laryngeal Nerve Invasion and Management of Thyroid Cancers
    • ​Greg Randolph, MD, FACS, FACE, Mass General Brigham/Mass Eye and Ear, Boston [S]
  • Targeted Therapy for RET Mutations in 2024
    • ​Jennifer Choe, MD, Duke University, Durham, North Carolina [M]
  • Q&A
2:35 p.m. - 3:00 p.m. Coffee Break
3:00 p.m. - 4:30 p.m. HPV Negative Head and Neck Cancer
Moderator: Dan Zandberg, MD, UPMC Hillman Cancer Center, Pittsburgh [M]
  • Genomic Alterations and Important Molecular Pathways in HPV Negative Patients
    • ​Christine Chung, MD, Moffitt Cancer Center, Tampa, Florida [M]
  • The Tumor Immune Microenvironment in HPV Negative Patients
    • ​Andrew Sikora, MD, PhD, MD Anderson Cancer Center, Houston [S]
  • Current Status and Future Directions in the Curative Intent Therapy in HPV
    • ​Doug Adkins, MD, FACP, Emory University, Atlanta [M]
  • Current Status and Future Directions in the Recurrent/Metastatic Setting in HPV Negative Patients
    • ​Nabil Saba, MD, FACP, Emory University, Atlanta [M]
  • Q&A
4:30 p.m. - 5:30 p.m. Salivary Gland Session
Moderator: Michael Moore, MD, Indiana University, Indianapolis [S]
  • Extent of Surgery for Primary Malignant Parotid Tumors
    • ​Samer Al-Khudari, MD, Rush University, Chicago [S]
  • From Zero to Proton Therapy: Indications for Adjuvant Radiotherapy in Salivary Cancer
    • ​Annie Chan, MD, Massachusetts General Hospital, Boston [R]
  • Molecular Profiling of Salivary Cancer: Indications and Applications
    • ​Renata Ferrarotto, MD, MD Anderson Cancer Center, Houston [M]
  • Q&A
Saturday, March 2, 2024
7:00 a.m. - 12:15 p.m. Registration Open
7:00 a.m. - 8:00 a.m. Continental Breakfast in the Exhibit Hall
7:55 a.m. - 8:00 a.m. Day Three Welcome
Julie Bauman, MD, MPH, George Washington Cancer Center, Washington, DC [M]
8:00 a.m. - 8:20 a.m. Patient Perspective
Speaker: Molly Cassidy, JD [Patient Speaker]
8:20 a.m. - 9:45 a.m. New Advances and Contemporary Management of Viral-Driven Head and Neck Cancer
Moderator: C. Jillian Tsai, MD, PhD, MS, Princess Margaret Cancer Center, Toronto, Ontario, Canada [R]
  • Advances in NPC Systemic and Other Novel Therapeutics
    • ​Cristina Rodriguez, MD, University of Washington, Seattle [M]
  • Molecular Profiling of Treatment Responses and Personalized Therapy for NPC
    • ​Melvin Lee Kiang Chua, MBBS, PhD, National Cancer Centre, Singapore [R]
  • Early Detection and Disease Surveillance for HPV-Related Oropharyngeal Cancers
    • ​Eleni Rettig, MD, Brigham and Women's Hospital, Boston [S]
  • Trends and Controversies in HPV De-Escalation Trials
    • ​Daniel Ma, MD, Mayo Clinic, Rochester, Minnesota [R]
  • Q&A
9:45 a.m. - 10:30 a.m. Supportive Care
Moderator: Assuntina Sacco, MD, University of California San Diego, La Jolla, California [M]
10:30 a.m. - 10:45 a.m. Coffee Break
10:45 a.m. - 12:15 p.m. Beyond the Battle: A Multidisciplinary Perspective on Head and Neck Cancer Survivorship
Moderator: Farzan Siddiqui, MD, PhD, Henry Ford Hospital, Detroit [R]
  • Body Image: A Critical Care and Under-Appreciated Concern among Head and Neck Cancer Survivors
    • ​Evan Graboyes, MD, Medical University of South Carolina, Charleston, South Carolina [S]
  • Going beyond Function: Developing a Life Worth Living in HNC Survivorship
    • ​Amy Williams, PhD, Indiana University, Indianapolis [Clinical Psychologist]
  • A Multidisciplinary Head and Neck Survivorship Program in a Comprehensive Cancer Center
    • ​Melanie Woodside, RN, MD, CON(C), University Health Network, Toronto, Ontario, Canada [Clinical Nurse Specialist]
  • Financial Toxicity in Long Term Survivors of Head and Neck Cancer
    • ​Zachary Zumsteg, MD, Cedars-Sinai Medical Center, Los Angeles [R]
  • Q&A

CO-SPONSORS

TERMS OF USE & PRIVACY POLICY

 

Connect With Us: